文献速递外周动脉疾病

药物不依从与下肢血运重建后更高发病率相关

Medication nonadherence is associated with higher morbidity after lower extremity revascularization in patients with peripheral arterial disease.
PubMed 文献 · J Vasc Surg · 2026-08-11

本研究纳入405例因外周动脉疾病(PAD)接受下肢腔内血运重建的患者,利用药房配药记录计算术后90天覆盖天数比例。结果显示62%达到复合依从标准,CLTI患者复合依从率比跛行患者低45%(87.7% vs 78.1%;P = .046)。药物不依从与死亡删失的再次干预、大截肢和小截肢风险显著升高相关,但与90天死亡率无关。

要点

  • PAD患者下肢腔内血运重建后药物不依从率较高,仅62%达到复合依从标准。
  • CLTI患者复合药物依从率显著低于跛行患者(87.7% vs 78.1%;P = .046)。
  • 药物依从与死亡删失的再次干预、大截肢和小截肢风险降低显著相关。

核心结论

  • 药物不依从显著增加下肢腔内血运重建后再次干预及大/小截肢风险。
  • 相当比例患者血运重建后不依从药物,CLTI患者为不依从高危群体。
  • 传统风险因素如区域剥夺指数和保险状态与依从性无关。

研究设计与样本

  • 共405例患者,45%为女性,39%为西班牙裔,18%为当前吸烟者,22%有跛行,78%有慢性肢体威胁性缺血(CLTI)。
  • 利用药房配药报告计算术后90天抗血小板药、抗凝药、他汀、抗高血压药、胰岛素及其他降糖药的覆盖天数比例。
  • 不依从定义为复合覆盖天数比例<80%。

主要发现

  • 不依从率从磺脲类的21.7%到短效胰岛素的54.1%不等,62%患者达到复合依从标准。
  • 97例(24%)接受再次干预,68例(17%)接受小截肢,39例(10%)接受大截肢,149例(37%)90天内再入院,16例(4%)90天内死亡。
  • 依从者与不依从者死亡率无差异(P = .90)。
  • 药物依从与死亡删失的再次干预风险降低61%相关(sHR 0.39;95%CI 0.27-0.58;P < .001)。
  • 药物依从与死亡删失的大截肢风险降低56%相关(sHR 0.44;95%CI 0.23-0.84;P = .01),与小截肢风险降低45%相关(sHR 0.55;95%CI 0.34-0.90;P = .02)。

关键数值与推荐

  • 不依从定义为术后90天复合覆盖天数比例<80%。
  • CLTI患者复合药物依从率较跛行患者低45%(87.7% vs 78.1%;P = .046)。
  • 药物依从与死亡删失的再次干预风险降低61%相关(sHR 0.39;95%CI 0.27-0.58;P < .001)。
  • 药物依从与死亡删失的大截肢风险降低56%相关(sHR 0.44;95%CI 0.23-0.84;P = .01)。
  • 药物依从与死亡删失的小截肢风险降低45%相关(sHR 0.55;95%CI 0.34-0.90;P = .02)。

临床怎么用

  • 下肢血运重建后应常规评估药物依从性,尤其对CLTI患者。
  • 提高药物依从可能降低再次干预和截肢风险,应作为术后管理重点。
  • 不应仅依据保险状态或区域剥夺指数判断不依从风险,需探索其他原因。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Medical management of peripheral artery disease (PAD) consists of antiplatelet therapy, cholesterol reduction, blood pressure control, and anticoagulation. These medications lead to lower mortality, improved quality of life, and fewer adverse limb events in patients with PAD. However, few studies have examined medication adherence rates, the factors that influence them, and the subsequent effect on outcomes. METHODS: We identified all patients who underwent lower extremity endovascular revascularization for PAD between May 2022 and November 2024. Pharmacy dispensing reports were utilized to calculate the proportion of days covered for 90 days postoperatively for antiplatelet agents, anticoagulants, statins, antihypertensives, insulin, and other antihyperglycemic agents. We evaluated the factors associated with nonadherence (defined as composite proportion of days covered of <80%) and the association between nonadherence and reintervention, minor and major amputation, and 90-day mortality. RESULTS: Our study population included 405 patients, of which 45% were female, 39% Hispanic, 18% current smokers, 22% had claudication, and 78% had chronic limb-threatening ischemia (CLTI). Nonadherence rates ranged from 21.7% for sulfonylureas to 54.1% for short-acting insulin. In our sample, 62% met the criteria for composite adherence. Patients with CLTI had 45% lower composite medication adherence compared with that for claudicants (87.7% vs 78.1%; P = .046). Moreover, 97 patients underwent reintervention (24%), 68 (17%) underwent minor amputation, 39 (10%) underwent major amputation, 149 (37%) were readmitted within 90 days, and 16 (4%) died within 90 days. While no difference was noted in mortality (P = .90) between adherent and nonadherent patients, medication adherence was associated with a 61% lower risk of death-censored reintervention (subdistribution hazard ratio [sHR], 0.39; 95% confidence interval [CI], 0.27-0.58, P < .001), 56% lower risk of death-censored major amputation (sHR, 0.44; 95% CI, 0.23-0.84; P = .01), and 45% lower risk of death-censored minor amputation (sHR, 0.55; 95% CI, 0.34-0.90; P = .02). Patients on dialysis had a higher risk of minor amputation (P = .007), and patients with CLTI had higher risks of reintervention (P = .017) and minor amputation (P = .032). Insurance status and area deprivation index were not associated with composite adherence. CONCLUSIONS: Medication nonadherence significantly increases the risks of reintervention and major/minor amputation following lower extremity endovascular revascularization. A significant proportion of patients are nonadherent to their medications following revascularization. Patients with CLTI comprise a high-risk group for nonadherence, with high rates of reintervention and amputation. Notably, traditionally accepted risk factors such as area deprivation index and insurance were not associated with adherence, suggesting that significant work is warranted to understand the reasons why patients are nonadherent to medications.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zhang MC, Sansosti AA, Zhao Y, et al. Medication nonadherence is associated with higher morbidity after lower extremity revascularization in patients with peripheral arterial disease. J Vasc Surg. 2026. PMID: 42575327. doi:10.1016/j.jvs.2026.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。